Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MarcyPen Capital Partners is a private equity and venture capital firm formed in September 2024 from the merger of Jay-Z’s Marcy Venture Partners and Pendulum Holdings. The combined entity manages $900 million in assets with an investment focus on early-stage and growth companies that are culturally relevant—primarily in consumer products, media, technology, and services. The firm has a strong mission to support Black entrepreneurs and foster economic growth within the Black community[5][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MarcyPen Capital Partners.